Pharmaceutical

Tevogen Bio partners Microsoft for HPV treatment

Tevogen Bio’s AI effort Tevogen.AI has partnered with Microsoft to advance the development of an HPV specific CTL treatment.

Nov 7, 2024 - 06:00
Tevogen Bio partners Microsoft for HPV treatment
Tevogen Bio’s AI effort Tevogen.AI has partnered with Microsoft to advance the development of an HPV specific CTL treatment.
Read the original article

Tags:

Previous Article

GSK CEO addresses declining trust in vaccines following Trump re-election

Next Article

Trump triumphs but impact on healthcare industry remains unclear

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Mesoblast plans new GvHD trial after another FDA rejection

Mesoblast plans new GvHD trial after another FDA rejection

Aug 4, 2023

FDA greenlights first over-the-counter birth control pill

FDA greenlights first over-the-counter birth control pill

Jul 13, 2023

Booster Therapeutics to develop proteasome activator medicines

Booster Therapeutics to develop proteasome activator me...

Oct 12, 2024